ORM1 and prostate cancer: The other five differentially abundant proteins had already been identified in exosomes from other human sample materials (e.g., ITIH2, in EVs from platelets and B, melanoma, mesenchymal stem, ovarian cancer, and prostate cancer cells; ORM1, in EVs from urine) (double asterisks in Table 2).